
Dr. Latanya Benjamin, MD, FAAD, FAAP, discusses the role of topical ruxolitinib cream in managing vitiligo and its effectiveness in a 25-year-old female patient.
Dr. Latanya Benjamin, MD, FAAD, FAAP, discusses the role of topical ruxolitinib cream in managing vitiligo and its effectiveness in a 25-year-old female patient.
A pediatric dermatologist reviews the case of a 25-year-old female with a history of vitiligo since adolescence who is affected by the social stigma of the condition.
Dr. Latanya Benjamin, MD, FAAD, FAAP, continues her discussion on a 35-year-old female patient with vitiligo by analyzing laboratory workup results and exploring advanced treatment decisions to optimize patient outcomes.
Highlighting the emotional impact of vitiligo on patients, Latanya Benjamin, MD, FAAD, FAAP, presents the case of a 35-year-old female patient with growing depigmentation in highly visible areas.
Dermatology Times recently spoke with Latanya Benjamin, MD, FAAD, FAAP, the newly-appointed president of the WDS, to discuss her hopes and goals for her presidency.
As your youngest patients begin the return to the classroom, pediatric dermatologist Latanya Benjamin, MD, FAAD, FAAP, offers perspectives in education and skin care tips.
Benjamin encouraged attendees at SCALE 2023 to think beyond just topicals for pediatric acne.
Published: July 4th 2024 | Updated:
Published: July 4th 2024 | Updated:
Published: July 4th 2024 | Updated:
Published: July 4th 2024 | Updated: